Doctors thought this kidney drug helped some patients. It may help millions more.
Large-scale international trials indicate that the kidney drug finerenone provides significant health benefits to a broader range of patients than previously recognized. The findings suggest the drug reduces the risk of kidney failure and cardiovascular death in non-diabetic patients.
Why it matters
Expanding the clinical application of this drug could improve treatment outcomes for millions of people suffering from chronic kidney disease.
Large international studies have found that the kidney disease drug finerenone may benefit far more patients than current treatment guidelines recommend.
The article reports on clinical trial results published in peer-reviewed journals without promotional bias.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in